A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Healthy and Asthmatic Participants

This study is testing multiple doses of a new inhaled drug called IBI3002 in healthy people and in people with asthma, to evaluate its safety, how well it is tolerated, and how the body processes it. **You may be eligible if...** - You are between the appropriate age ranges for your group - Your body weight and BMI fall within the acceptable range (BMI 18–32 kg/m²) - For the asthma part: you have been diagnosed with asthma for at least 12 months - For the asthma part: your asthma is moderate-to-severe and not fully controlled - For the asthma part: you have evidence of reversible airway narrowing on lung function tests **You may NOT be eligible if...** - You have poorly controlled asthma requiring recent hospitalization - You have significant heart, liver, kidney, or other serious medical conditions - You are pregnant or breastfeeding - You have recently used other inhaled medications that could interfere with the study drug - You smoke or have recently quit smoking Talk to your doctor to see if this trial is right for you.